{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T10:39:49Z","timestamp":1789468789432,"version":"build-2803163510"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["203128\/Z\/16\/Z"],"award-info":[{"award-number":["203128\/Z\/16\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["202860\/Z\/16\/Z"],"award-info":[{"award-number":["202860\/Z\/16\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000291","name":"Kidney Research UK","doi-asserted-by":"crossref","award":["K1199"],"award-info":[{"award-number":["K1199"]}],"id":[{"id":"10.13039\/501100000291","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1007\/s00467-019-04241-7","type":"journal-article","created":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T07:03:22Z","timestamp":1556694202000},"page":"733-742","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["The importance of clinician, patient and researcher collaborations in Alport syndrome"],"prefix":"10.1007","volume":"35","author":[{"given":"Michelle N.","family":"Rheault","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Savige","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Randles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Weinstock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Stepney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A Neil","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gina","family":"Parziale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Gross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances A","family":"Flinter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey H","family":"Miner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Lagas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susie","family":"Gear","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6400-0227","authenticated-orcid":false,"given":"Rachel","family":"Lennon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,1]]},"reference":[{"key":"4241_CR1","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/ki.2014.229","volume":"86","author":"JH Miner","year":"2014","unstructured":"Miner JH, Baigent C, Flinter F, Gross O, Judge P, Kashtan CE, Lagas S, Savige J, Blatt D, Ding J, Gale DP, Midgley JP, Povey S, Prunotto M, Renault D, Skelding J, Turner AN, Gear S (2014) The 2014 International Workshop on Alport Syndrome. Kidney Int 86:679\u2013684","journal-title":"Kidney Int"},{"key":"4241_CR2","first-page":"916","volume":"32","author":"O Gross","year":"2017","unstructured":"Gross O, Kashtan CE, Rheault MN, Flinter F, Savige J, Miner JH, Torra R, Ars E, Deltas C, Savva I, Perin L, Renieri A, Ariani F, Mari F, Baigent C, Judge P, Knebelman B, Heidet L, Lagas S, Blatt D, Ding J, Zhang Y, Gale DP, Prunotto M, Xue Y, Schachter AD, Morton LCG, Blem J, Huang M, Liu S, Vallee S, Renault D, Schifter J, Skelding J, Gear S, Friede T, Turner AN, Lennon R (2017) Advances and unmet needs in genetic, basic and clinical science in Alport syndrome: report from the 2015 International Workshop on Alport Syndrome. Nephrol Dial Transplant 32:916\u2013924","journal-title":"Nephrol Dial Transplant"},{"key":"4241_CR3","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1007\/s00467-015-3067-9","volume":"30","author":"R Lennon","year":"2015","unstructured":"Lennon R, Stuart HM, Bierzynska A, Randles MJ, Kerr B, Hillman KA, Batra G, Campbell J, Storey H, Flinter FA, Koziell A, Welsh GI, Saleem MA, Webb NJ, Woolf AS (2015) Coinheritance of COL4A5 and MYO1E mutations accentuate the severity of kidney disease. Pediatr Nephrol 30:1459\u20131465","journal-title":"Pediatr Nephrol"},{"key":"4241_CR4","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1038\/ki.2014.305","volume":"86","author":"AF Malone","year":"2014","unstructured":"Malone AF, Phelan PJ, Hall G, Cetincelik U, Homstad A, Alonso AS, Jiang R, Lindsey TB, Wu G, Sparks MA, Smith SR, Webb NJ, Kalra PA, Adeyemo AA, Shaw AS, Conlon PJ, Jennette JC, Howell DN, Winn MP, Gbadegesin RA (2014) Rare hereditary COL4A3\/COL4A4 variants may be mistaken for familial focal segmental glomerulosclerosis. Kidney Int 86:1253\u20131259","journal-title":"Kidney Int"},{"key":"4241_CR5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00467-012-2138-4","volume":"28","author":"CE Kashtan","year":"2013","unstructured":"Kashtan CE, Ding J, Gregory M, Gross O, Heidet L, Knebelmann B, Rheault M, Licht C, Alport Syndrome Research Collaborative (2013) Clinical practice recommendations for the treatment of Alport syndrome: a statement of the Alport Syndrome Research Collaborative. Pediatr Nephrol 28:5\u201311","journal-title":"Pediatr Nephrol"},{"key":"4241_CR6","doi-asserted-by":"publisher","first-page":"436046","DOI":"10.5402\/2012\/436046","volume":"2012","author":"O Gross","year":"2012","unstructured":"Gross O, Friede T, Hilgers R, Gorlitz A, Gavenis K, Ahmed R, Durr U (2012) Safety and efficacy of the ACE-inhibitor ramipril in Alport syndrome: the double-blind, randomized, placebo-controlled, multicenter phase III EARLY PRO-TECT Alport trial in pediatric patients. ISRN Pediatr 2012:436046","journal-title":"ISRN Pediatr"},{"key":"4241_CR7","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1136\/archdischild-2014-307423","volume":"100","author":"A Nagra","year":"2015","unstructured":"Nagra A, McGinnity PM, Davis N, Salmon AP (2015) Implementing transition: ready steady go. Arch Dis Child Educ Pract Ed 100:313\u2013320","journal-title":"Arch Dis Child Educ Pract Ed"},{"key":"4241_CR8","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/s00404-015-3893-9","volume":"293","author":"E Yefet","year":"2016","unstructured":"Yefet E, Tovbin D, Nachum Z (2016) Pregnancy outcomes in patients with Alport syndrome. Arch Gynecol Obstet 293:739\u2013747","journal-title":"Arch Gynecol Obstet"},{"key":"4241_CR9","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1053\/j.ajkd.2016.04.022","volume":"68","author":"M Hall","year":"2016","unstructured":"Hall M (2016) Pregnancy in women with CKD: a success story. Am J Kidney Dis 68:633\u2013639","journal-title":"Am J Kidney Dis"},{"key":"4241_CR10","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s00467-012-2272-z","volume":"28","author":"D Noone","year":"2013","unstructured":"Noone D, Licht C (2013) An update on the pathomechanisms and future therapies of Alport syndrome. Pediatr Nephrol 28:1025\u20131036","journal-title":"Pediatr Nephrol"},{"key":"4241_CR11","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.kint.2016.02.018","volume":"90","author":"B Dufek","year":"2016","unstructured":"Dufek B, Meehan DT, Delimont D, Cheung L, Gratton MA, Phillips G, Song W, Liu S, Cosgrove D (2016) Endothelin A receptor activation on mesangial cells initiates Alport glomerular disease. Kidney Int 90:300\u2013310","journal-title":"Kidney Int"},{"key":"4241_CR12","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1681\/ASN.2012020148","volume":"24","author":"J Savige","year":"2013","unstructured":"Savige J, Gregory M, Gross O, Kashtan C, Ding J, Flinter F (2013) Expert guidelines for the management of Alport syndrome and thin basement membrane nephropathy. J Am Soc Nephrol 24:364\u2013375","journal-title":"J Am Soc Nephrol"},{"key":"4241_CR13","doi-asserted-by":"publisher","first-page":"e0161802","DOI":"10.1371\/journal.pone.0161802","volume":"11","author":"J Savige","year":"2016","unstructured":"Savige J, Storey H, Il Cheong H, Gyung Kang H, Park E, Hilbert P, Persikov A, Torres-Fernandez C, Ars E, Torra R, Hertz JM, Thomassen M, Shagam L, Wang D, Wang Y, Flinter F, Nagel M (2016) X-linked and autosomal recessive Alport syndrome: pathogenic variant features and further genotype-phenotype correlations. PLoS One 11:e0161802","journal-title":"PLoS One"},{"key":"4241_CR14","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1093\/ndt\/gfv325","volume":"31","author":"C Gast","year":"2016","unstructured":"Gast C, Pengelly RJ, Lyon M, Bunyan DJ, Seaby EG, Graham N, Venkat-Raman G, Ennis S (2016) Collagen (COL4A) mutations are the most frequent mutations underlying adult focal segmental glomerulosclerosis. Nephrol Dial Transplant 31:961\u2013970","journal-title":"Nephrol Dial Transplant"},{"key":"4241_CR15","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1007\/s00467-008-0934-7","volume":"23","author":"S Tonna","year":"2008","unstructured":"Tonna S, Wang YY, Wilson D, Rigby L, Tabone T, Cotton R, Savige J (2008) The R229Q mutation in NPHS2 may predispose to proteinuria in thin-basement-membrane nephropathy. Pediatr Nephrol 23:2201\u20132207","journal-title":"Pediatr Nephrol"},{"key":"4241_CR16","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1038\/ejhg.2014.252","volume":"23","author":"G Bullich","year":"2015","unstructured":"Bullich G, Trujillano D, Santin S, Ossowski S, Mendizabal S, Fraga G, Madrid A, Ariceta G, Ballarin J, Torra R, Estivill X, Ars E (2015) Targeted next-generation sequencing in steroid-resistant nephrotic syndrome: mutations in multiple glomerular genes may influence disease severity. Eur J Hum Genet 23:1192\u20131199","journal-title":"Eur J Hum Genet"},{"key":"4241_CR17","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1097\/01.ASN.0000090034.71205.74","volume":"14","author":"JP Jais","year":"2003","unstructured":"Jais JP, Knebelmann B, Giatras I, De Marchi M, Rizzoni G, Renieri A, Weber M, Gross O, Netzer KO, Flinter F, Pirson Y, Dahan K, Wieslander J, Persson U, Tryggvason K, Martin P, Hertz JM, Schroder C, Sanak M, Carvalho MF, Saus J, Antignac C, Smeets H, Gubler MC (2003) X-linked Alport syndrome: natural history and genotype-phenotype correlations in girls and women belonging to 195 families: a \u201cEuropean Community Alport Syndrome Concerted Action\u201d study. J Am Soc Nephrol 14:2603\u20132610","journal-title":"J Am Soc Nephrol"},{"key":"4241_CR18","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1681\/ASN.V114649","volume":"11","author":"JP Jais","year":"2000","unstructured":"Jais JP, Knebelmann B, Giatras I, De Marchi M, Rizzoni G, Renieri A, Weber M, Gross O, Netzer KO, Flinter F, Pirson Y, Verellen C, Wieslander J, Persson U, Tryggvason K, Martin P, Hertz JM, Schroder C, Sanak M, Krejcova S, Carvalho MF, Saus J, Antignac C, Smeets H, Gubler MC (2000) X-linked Alport syndrome: natural history in 195 families and genotype- phenotype correlations in males. J Am Soc Nephrol 11:649\u2013657","journal-title":"J Am Soc Nephrol"},{"key":"4241_CR19","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1038\/ki.2011.452","volume":"81","author":"J Temme","year":"2012","unstructured":"Temme J, Peters F, Lange K, Pirson Y, Heidet L, Torra R, Grunfeld JP, Weber M, Licht C, Muller GA, Gross O (2012) Incidence of renal failure and nephroprotection by RAAS inhibition in heterozygous carriers of X-chromosomal and autosomal recessive Alport mutations. Kidney Int 81:779\u2013783","journal-title":"Kidney Int"},{"key":"4241_CR20","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/ki.2011.407","volume":"81","author":"O Gross","year":"2012","unstructured":"Gross O, Licht C, Anders HJ, Hoppe B, Beck B, Tonshoff B, Hocker B, Wygoda S, Ehrich JH, Pape L, Konrad M, Rascher W, Dotsch J, Muller-Wiefel DE, Hoyer P, Study Group Members of the Gesellschaft f\u00fcr P\u00e4diatrische Nephrologie, Knebelmann B, Pirson Y, Grunfeld JP, Niaudet P, Cochat P, Heidet L, Lebbah S, Torra R, Friede T, Lange K, Muller GA, Weber M (2012) Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy. Kidney Int 81:494\u2013501","journal-title":"Kidney Int"},{"key":"4241_CR21","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.kint.2017.12.018","volume":"93","author":"CE Kashtan","year":"2018","unstructured":"Kashtan CE, Ding J, Garosi G, Heidet L, Massella L, Nakanishi K, Nozu K, Renieri A, Rheault M, Wang F, Gross O (2018) Alport syndrome: a unified classification of genetic disorders of collagen IV alpha345: a position paper of the Alport Syndrome Classification Working Group. Kidney Int 93:1045\u20131051","journal-title":"Kidney Int"},{"key":"4241_CR22","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.2215\/CJN.00580116","volume":"11","author":"J Savige","year":"2016","unstructured":"Savige J, Colville D, Rheault M, Gear S, Lennon R, Lagas S, Finlay M, Flinter F (2016) Alport syndrome in women and girls. Clin J Am Soc Nephrol 11:1713\u20131720","journal-title":"Clin J Am Soc Nephrol"},{"key":"4241_CR23","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1046\/j.1523-1755.2003.00234.x","volume":"64","author":"J Savige","year":"2003","unstructured":"Savige J, Rana K, Tonna S, Buzza M, Dagher H, Wang YY (2003) Thin basement membrane nephropathy. Kidney Int 64:1169\u20131178","journal-title":"Kidney Int"},{"key":"4241_CR24","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1111\/cge.13077","volume":"92","author":"L Papazachariou","year":"2017","unstructured":"Papazachariou L, Papagregoriou G, Hadjipanagi D, Demosthenous P, Voskarides K, Koutsofti C, Stylianou K, Ioannou P, Xydakis D, Tzanakis I, Papadaki A, Kallivretakis N, Nikolakakis N, Perysinaki G, Gale DP, Diamantopoulos A, Goudas P, Goumenos D, Soloukides A, Boletis I, Melexopoulou C, Georgaki E, Frysira E, Komianou F, Grekas D, Paliouras C, Alivanis P, Vergoulas G, Pierides A, Daphnis E, Deltas C (2017) Frequent COL4 mutations in familial microhematuria accompanied by later-onset Alport nephropathy due to focal segmental glomerulosclerosis. Clin Genet 92:517\u2013527","journal-title":"Clin Genet"},{"key":"4241_CR25","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL, ACMG Laboratory Quality Assurance Committee (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17:405\u2013424","journal-title":"Genet Med"},{"key":"4241_CR26","doi-asserted-by":"publisher","unstructured":"Fidler AL, Darris CE, Chetyrkin SV, Pedchenko VK, Boudko SP, Brown KL, Gray Jerome W, Hudson JK, Rokas A, Hudson BG (2017) Collagen IV and basement membrane at the evolutionary dawn of metazoan tissues. Elife. https:\/\/doi.org\/10.7554\/eLife.24176","DOI":"10.7554\/eLife.24176"},{"key":"4241_CR27","doi-asserted-by":"crossref","first-page":"8597","DOI":"10.1016\/S0021-9258(19)75262-4","volume":"252","author":"RG Price","year":"1977","unstructured":"Price RG, Spiro RG (1977) Studies on the metabolism of the renal glomerular basement membrane. Turnover measurements in the rat with the use of radiolabeled amino acids. J Biol Chem 252:8597\u20138602","journal-title":"J Biol Chem"},{"key":"4241_CR28","doi-asserted-by":"publisher","first-page":"F1101","DOI":"10.1152\/ajprenal.00020.2017","volume":"312","author":"W Kriz","year":"2017","unstructured":"Kriz W, Lowen J, Federico G, van den Born J, Grone E, Grone HJ (2017) Accumulation of worn-out GBM material substantially contributes to mesangial matrix expansion in diabetic nephropathy. Am J Physiol Ren Physiol 312:F1101\u2013F1111","journal-title":"Am J Physiol Ren Physiol"},{"key":"4241_CR29","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s00467-016-3358-9","volume":"32","author":"W Kriz","year":"2017","unstructured":"Kriz W, Lemley KV (2017) Mechanical challenges to the glomerular filtration barrier: adaptations and pathway to sclerosis. Pediatr Nephrol 32:405\u2013417","journal-title":"Pediatr Nephrol"},{"key":"4241_CR30","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1007\/s00424-017-2025-8","volume":"469","author":"K Endlich","year":"2017","unstructured":"Endlich K, Kliewe F, Endlich N (2017) Stressed podocytes-mechanical forces, sensors, signaling and response. Pflugers Arch 469:937\u2013949","journal-title":"Pflugers Arch"},{"key":"4241_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000422954","volume":"107","author":"W Kriz","year":"1994","unstructured":"Kriz W, Mundel P, Elger M (1994) The contractile apparatus of podocytes is arranged to counteract GBM expansion. Contrib Nephrol 107:1\u20139","journal-title":"Contrib Nephrol"},{"key":"4241_CR32","first-page":"S2","volume":"30","author":"W Kriz","year":"1990","unstructured":"Kriz W, Elger M, Lemley K, Sakai T (1990) Structure of the glomerular mesangium: a biomechanical interpretation. Kidney Int Suppl 30:S2\u2013S9","journal-title":"Kidney Int Suppl"},{"key":"4241_CR33","doi-asserted-by":"publisher","first-page":"16776","DOI":"10.1038\/s41598-017-16603-y","volume":"7","author":"CP Chu","year":"2017","unstructured":"Chu CP, Hokamp JA, Cianciolo RE, Dabney AR, Brinkmeyer-Langford C, Lees GE, Nabity MB (2017) RNA-seq of serial kidney biopsies obtained during progression of chronic kidney disease from dogs with X-linked hereditary nephropathy. Sci Rep 7:16776","journal-title":"Sci Rep"},{"key":"4241_CR34","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1038\/nprot.2016.098","volume":"11","author":"M Takasato","year":"2016","unstructured":"Takasato M, Er PX, Chiu HS, Little MH (2016) Generation of kidney organoids from human pluripotent stem cells. Nat Protoc 11:1681\u20131692","journal-title":"Nat Protoc"},{"key":"4241_CR35","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/nature15695","volume":"526","author":"M Takasato","year":"2015","unstructured":"Takasato M, Er PX, Chiu HS, Maier B, Baillie GJ, Ferguson C, Parton RG, Wolvetang EJ, Roost MS, Chuva de Sousa Lopes SM, Little MH (2015) Kidney organoids from human iPS cells contain multiple lineages and model human nephrogenesis. Nature 526:564\u2013568","journal-title":"Nature"},{"key":"4241_CR36","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1681\/ASN.2011030243","volume":"23","author":"S Sedrakyan","year":"2012","unstructured":"Sedrakyan S, Da Sacco S, Milanesi A, Shiri L, Petrosyan A, Varimezova R, Warburton D, Lemley KV, De Filippo RE, Perin L (2012) Injection of amniotic fluid stem cells delays progression of renal fibrosis. J Am Soc Nephrol 23:661\u2013673","journal-title":"J Am Soc Nephrol"},{"key":"4241_CR37","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1159\/000102520","volume":"30","author":"J Krtil","year":"2007","unstructured":"Krtil J, Platenik J, Kazderova M, Tesar V, Zima T (2007) Culture methods of glomerular podocytes. Kidney Blood Press Res 30:162\u2013174","journal-title":"Kidney Blood Press Res"},{"key":"4241_CR38","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1172\/JCI75852","volume":"125","author":"IG Gomez","year":"2015","unstructured":"Gomez IG, MacKenna DA, Johnson BG, Kaimal V, Roach AM, Ren S, Nakagawa N, Xin C, Newitt R, Pandya S, Xia TH, Liu X, Borza DB, Grafals M, Shankland SJ, Himmelfarb J, Portilla D, Liu S, Chau BN, Duffield JS (2015) Anti-microRNA-21 oligonucleotides prevent Alport nephropathy progression by stimulating metabolic pathways. J Clin Invest 125:141\u2013156","journal-title":"J Clin Invest"},{"key":"4241_CR39","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1093\/ndt\/gfx246","volume":"33","author":"T Yokota","year":"2018","unstructured":"Yokota T, Omachi K, Suico MA, Kamura M, Kojima H, Fukuda R, Motomura K, Teramoto K, Kaseda S, Kuwazuru J, Takeo T, Nakagata N, Shuto T, Kai H (2018) STAT3 inhibition attenuates the progressive phenotypes of Alport syndrome mouse model. Nephrol Dial Transplant 33:214\u2013223","journal-title":"Nephrol Dial Transplant"},{"key":"4241_CR40","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.cell.2014.05.009","volume":"157","author":"AS McCall","year":"2014","unstructured":"McCall AS, Cummings CF, Bhave G, Vanacore R, Page-McCaw A, Hudson BG (2014) Bromine is an essential trace element for assembly of collagen IV scaffolds in tissue development and architecture. Cell 157:1380\u20131392","journal-title":"Cell"},{"key":"4241_CR41","doi-asserted-by":"publisher","first-page":"e0183959","DOI":"10.1371\/journal.pone.0183959","volume":"12","author":"T Yokota","year":"2017","unstructured":"Yokota T, Omachi K, Suico MA, Kojima H, Kamura M, Teramoto K, Kaseda S, Kuwazuru J, Shuto T, Kai H (2017) Bromide supplementation exacerbated the renal dysfunction, injury and fibrosis in a mouse model of Alport syndrome. PLoS One 12:e0183959","journal-title":"PLoS One"},{"key":"4241_CR42","doi-asserted-by":"crossref","unstructured":"Gann B (2013) Understanding and using experiences of health and illness: the policy landscape. In: Ziebland S C, A., Calabrese, J., Locock, L, (ed) Understanding and using health experiences OUP, Oxford","DOI":"10.1093\/acprof:oso\/9780199665372.003.0015"},{"key":"4241_CR43","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1258\/jms.2011.010143","volume":"18","author":"SEJ Prinjha","year":"2011","unstructured":"Prinjha SEJ, Ziebland S, McPherson A (2011) A mastectomy for something that wasn't even truly invasive cancer. Women\u2019s understandings of having a mastectomy for screen-detected DCIS: a qualitative study. J Med Screen 18:34\u201340","journal-title":"J Med Screen"},{"key":"4241_CR44","doi-asserted-by":"publisher","first-page":"d2245","DOI":"10.1136\/bmj.d2245","volume":"342","author":"J Feinmann","year":"2011","unstructured":"Feinmann J (2011) Listening to patients\u2019 narratives can help improve quality of psychosis care. BMJ 342:d2245","journal-title":"BMJ"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-019-04241-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-019-04241-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-019-04241-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T06:22:46Z","timestamp":1694845366000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-019-04241-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,1]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["4241"],"URL":"https:\/\/doi.org\/10.1007\/s00467-019-04241-7","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,1]]},"assertion":[{"value":"24 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"MR receives research funding from Regulus Therapeutics and Reata Pharmaceuticals. The other authors declare no conflicts of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}